Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Copper-clad laminate (CCL) upgrades to higher precision packaging substrates

Copper-clad laminate (CCL) upgrades to higher precision packaging substrates

404k404k2026/10/05 09:19
Show original
Copper Clad Laminate (CCL) upgrades shift focus to higher-precision substrate packaging; Nanya, Unimicron hit record highs, Taiguang Electronics and Taya Technology hit limit-upPreviously, the market was concerned that the broader adoption of Co-Packaged Optics (CPO) could shorten the transmission distance of high-speed signals, thereby reducing demand for high-end CCL. As a result, CCL stocks came under heavy selling pressure.However, industry insiders indicate that the CCL upgrade cycle is far from over. The focus of material upgrades is shifting toward applications with higher precision requirements, including semiconductor packaging substrates and optical engine module boards.On October 5, CCL-related stocks surged. Taiguang Electronics (2383) and Taya Technology (6274) hit their upper price limits, while Nanya Plastics (1303), Unimicron (6213), and Tenghui Electronics-KY (6672) reached new intraday highs.According to industry sources, high-end CCL shipments have remained robust this year, with both volume and prices continuing to rise. The next phase of material upgrades is expected to concentrate on substrate miniaturization, as well as customized thermal characteristics and tighter control of Coefficient of Thermal Expansion (CTE).As a result, the upgrade path is shifting from large-area server and switch motherboards to semiconductor packaging substrates and optical engine module boards. CCL manufacturers capable of expanding advanced substrate materials and high-end specialty resin formulations are expected to continue benefiting as major players in the ongoing technological evolution of the industry.Meanwhile, CPO still faces several short-term challenges, including cost, manufacturing yield, reliability, maintenance, and thermal management. Therefore, its impact on high-end CCL demand is expected to remain limited in the short term.Demand for large-area motherboards used in AI servers and 800G/1.6T switches also remains solid, continuing to support the high-performance CCL materials market.Analysts point out that materials of M7 grade and above currently account for about 60% to 65% of Taiguang Electronics' business. The company began shipping M9 products in the third quarter of this year and plans to increase their prices.On Monday, Taiguang Electronics' share price opened sharply higher and then quickly rose to the daily limit at NT$5,700, surpassing the 60-day moving average.Nanya Plastics, Unimicron, and Tenghui Electronics-KY also hit new intraday historical highs. Among them, Nanya saw the largest increase, at one point rising nearly 9% to NT$285.Supply chain surveys show that Nanya’s high-end M6 to M8 CCL orders used for AI servers are expected to make significant progress in the fourth quarter.Nanya is also developing proprietary hydrocarbon resin formulations for high-grade M9 and M10 materials. The company and another Taiwanese supplier are currently undergoing sample certification for M10 materials, with initial verification results expected in the first quarter of 2027.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Will the 30-year yield break 6% this month? Economic resilience and inflation pressures drive rates higher, further intensifying the sell-off in US Treasury bonds

U.S. Treasury bonds faced another round of sell-offs on Monday, pushing long-term yields to their highest levels in decades.

智通财经•2026/10/05 23:22

Allegion Buys Overly Door Company

05:37 PM EDT, 10/05/2026 (MT Newswires) -- Allegion (ALLE) said late Monday it has acquired privately held Overly Door Company, a manufacturer of custom specialty doors for acoustic, blast, bullet-resistant and vault security. Overly, based in Greensburg, Pennsylvania, will operate as part of the Allegion Americas segment, it said. Terms of the transaction weren't disclosed.

MT newswire•2026/10/05 21:37

Updated Version 3 - According to the Financial Times, McKesson and CD&R are close to reaching a deal worth more than $5 billion to acquire Option Care.

In the fifth paragraph, a quote from analyst Sahil Pandey was added. Reuters, October 5 - According to the Financial Times, citing informed sources, pharmaceutical distributor McKesson (MCK.N) and private equity firm Clayton Dubilier & Rice are about to reach an acquisition agreement to purchase infusion service provider Option Care Health, with the deal valued (including debt) at over 5 billions USD. After the report was published, Option Care's share price rose by 21% in after-hours trading. The report stated that the deal could be announced as early as Tuesday, but negotiations could still fall through. This potential acquisition would be McKesson’s latest move in expanding its healthcare services portfolio. In August this year, the company agreed to acquire Precision Medicine Group for about 2.25 billions USD (link), as part of its effort over the years to strengthen high-growth business sectors. Leerink Partners analyst Michael Cherny said the “strategic logic” of the deal makes sense, as it would expand McKesson’s business from physician offices to care settings in the home and alternative sites. Option Care provides infusion services that allow patients to receive intravenous treatments at home or other outpatient settings, eliminating the need to go to the hospital. McKesson has previously been restructuring its business portfolio by divesting non-core assets and investing in fields such as oncology and specialty care (link). Driven by the growth of its specialty distribution business and contributions from acquisitions, revenue for its oncology and multi-specialty business segment grew by 33% in the latest fiscal quarter. McKesson declined to comment, while CD&R and Option Care did not immediately respond to Reuters’ requests for comment regarding the report. (For non-English speakers' convenience, Reuters offers automated machine translations of its reports in several languages. As there may be mistakes in the automated translations or some context may not be included, Reuters does not guarantee the accuracy of the automated translation text, which is provided solely for readers’ convenience. Reuters bears no responsibility for any damages or losses caused by the use of automated translation functions.)

路透社•2026/10/05 21:18